SAN CARLOS, Calif., March 10 /PRNewswire-FirstCall/ -- Nektar Therapeutics' President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming Cowen and Company 29th Annual Healthcare Conference in Boston at the Boston Marriott Copley Plaza on Monday, March 16, 2009 at 2:25 p.m. Eastern time.
The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay until April 1, 2009.
About Nektar
Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own potentially high-value therapeutics that addresses unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules. For more information on Nektar Therapeutics, please visit http://www.nektar.com.
CONTACT: Jennifer Ruddock of Nektar Therapeutics, +1-650-631-4954,
jruddock@nektar.com; or Susan Noonan of The SAN Group, +1-212-966-3650,
susan@sanoonan.com, for Nektar Therapeutics
Web site: http://www.nektar.com/
